http://orcid.org/0000-0001-7824-4644
References
- Campenhout AV, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis. 2009;204(2):321–329.
- Hofbauer LC, Shui C, Riggs BL, Dunstan CR, et al. Effects of immunosuppressants on receptor activator of NF-kB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun. 2001;280(1):334–339.
- Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. ATVB. 2001;21(12):1998–2003.
- Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor Perspect Biol . 2014;6(1):a009191–a009191.
- Eshre TR. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
- Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861.
- Inan C, Karadag C. Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome. Pak J Med Sci. 2016;32(3):742–745.
- Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome – part 2. Endocr Pract. 2015;21(12):1415–1426.,
- Rochette L, Meloux A, Rigal E, et al. The role of osteoprotegerin and its ligands in vascular function. Int J Mol Sci. 2019;20(3):705.
- Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309–319.
- Mangan S, Campenhout A, Rush C, et al. Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2. Cardiovasc Res. 2007;76(3):494–505.
- Schaalan M, Mohamed W. Predictive ability of circulating osteoprotegerin as a novel biomarker for early detection of acute kidney injury induced by sepsis. Eur Cytokine Netw. 2017;28(2):52–62.
- Shaaban Z, Khoradmehr A, Shirazi MR, et al. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3–16.
- Escobar-Morreale HF, Botella-Carretero JI, Martinez-Garcia MA, et al. Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. Eur J Endocrinol. 2008;159(3):225–232.
- Pepene CE, Ilie IR, Marian I, et al. Circulating osteoprotegerin and soluble receptor activator of nuclear factor kB ligand in polycystic ovary syndrome:relationships to insulin resistance and endothelial dysfunction. Eur J Endocrinol. 2011;164(1):61–68.
- Abali R, Tasdemir N, Alpsoy S, et al. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome. Arch Gynecol Obstet. 2015;291(5):1075–1080.
- Chen Q, Kaji H, Kanatani M, et al. Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res. 2004;36(10):674–678.,
- Clarke BL, Khosla S. Androgens and bone. Steroids. 2009;74(3):296–305.
- Huber DM, Bendixen AC, Pathrose P, et al. Androgens suppress osteoclast formation induced by RANKL and macrophage colony stimulating factor. Endocrinology. 2001;142(9):3800–3808.
- Roland AV, Moenter SM. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models. Front Neuroendocrinol. 2014;35(4):494–511.
- Luque-Ramírez M, San Millán JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta. 2006;366(1–2):14–26.
- Hosbond SE, Poulsen TS, Diederichsen AC, et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. Scand Cardiovasc J. 2012;46(4):203–211.
- Ciccone MM, Scicchitano P, Gesualdo M, et al. Serum osteoprotegerin and carotid intima–media thickness in acute/chronic coronary artery diseases. J Cardiovasc Med. 2013;14:43–48.